Business Description
Ningbo David Medical Device Co Ltd
NAICS : 334510
SIC : 3845
ISIN : CNE100001DD1
Share Class Description:
SZSE:300314: Class ACompare
Compare
Traded in other countries / regions
300314.China IPO Date
2012-05-08Description
Ningbo David Medical Device Co Ltd operates in the medical device industry. The company specializes in an independent research and development, production and distribution of medical equipment. The main products of the company are infant incubator, transport incubator, infant radiant warmer, neonate bilirubin phototherapy equipment and infant resuscitator.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 59.36 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.08 | |||||
| Interest Coverage | 237.32 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 13.44 | |||||
| Beneish M-Score | -1.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.4 | |||||
| 3-Year EBITDA Growth Rate | 16.4 | |||||
| 3-Year EPS without NRI Growth Rate | 1.5 | |||||
| 3-Year FCF Growth Rate | -5.8 | |||||
| 3-Year Book Growth Rate | 6.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.17 | |||||
| 9-Day RSI | 58.42 | |||||
| 14-Day RSI | 52.41 | |||||
| 6-1 Month Momentum % | -20.88 | |||||
| 12-1 Month Momentum % | -43.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.42 | |||||
| Quick Ratio | 5.34 | |||||
| Cash Ratio | 4.84 | |||||
| Days Inventory | 220.42 | |||||
| Days Sales Outstanding | 19.02 | |||||
| Days Payable | 137.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.34 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| 3-Year Dividend Growth Rate | 55.4 | |||||
| Forward Dividend Yield % | 1.34 | |||||
| 5-Year Yield-on-Cost % | 3.71 | |||||
| Shareholder Yield % | 1.48 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.01 | |||||
| Operating Margin % | 22.2 | |||||
| Net Margin % | 22.04 | |||||
| FCF Margin % | 7.1 | |||||
| ROE % | 11.86 | |||||
| ROA % | 10.26 | |||||
| ROIC % | 28.16 | |||||
| ROC (Joel Greenblatt) % | 60.5 | |||||
| ROCE % | 13.22 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 23.8 | |||||
| PE Ratio without NRI | 23.35 | |||||
| Shiller PE Ratio | 38.48 | |||||
| Price-to-Owner-Earnings | 29.62 | |||||
| PEG Ratio | 1.14 | |||||
| PS Ratio | 5.21 | |||||
| PB Ratio | 2.68 | |||||
| Price-to-Tangible-Book | 2.78 | |||||
| Price-to-Free-Cash-Flow | 74.5 | |||||
| Price-to-Operating-Cash-Flow | 27.46 | |||||
| EV-to-EBIT | 16.1 | |||||
| EV-to-EBITDA | 16.1 | |||||
| EV-to-Revenue | 4.01 | |||||
| EV-to-FCF | 53.71 | |||||
| Price-to-Projected-FCF | 1.67 | |||||
| Price-to-Median-PS-Value | 0.5 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.93 | |||||
| Price-to-Graham-Number | 1.7 | |||||
| Price-to-Net-Current-Asset-Value | 4.01 | |||||
| Price-to-Net-Cash | 5.72 | |||||
| Earnings Yield (Greenblatt) % | 6.21 | |||||
| FCF Yield % | 1.36 | |||||
| Forward Rate of Return (Yacktman) % | 22.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ningbo David Medical Device Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 615.765 | ||
| EPS (TTM) (Â¥) | 0.469 | ||
| Beta | 0.53 | ||
| Volatility % | 36.52 | ||
| 14-Day RSI | 52.41 | ||
| 14-Day ATR (Â¥) | 0.471822 | ||
| 20-Day SMA (Â¥) | 10.905 | ||
| 12-1 Month Momentum % | -43.96 | ||
| 52-Week Range (Â¥) | 8.23 - 22.63 | ||
| Shares Outstanding (Mil) | 288 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ningbo David Medical Device Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ningbo David Medical Device Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ningbo David Medical Device Co Ltd Frequently Asked Questions
What is Ningbo David Medical Device Co Ltd(SZSE:300314)'s stock price today?
The current price of SZSE:300314 is ¥11.16. The 52 week high of SZSE:300314 is ¥22.63 and 52 week low is ¥8.23.
When is next earnings date of Ningbo David Medical Device Co Ltd(SZSE:300314)?
The next earnings date of Ningbo David Medical Device Co Ltd(SZSE:300314) is .
Does Ningbo David Medical Device Co Ltd(SZSE:300314) pay dividends? If so, how much?
The Dividend Yield %  of Ningbo David Medical Device Co Ltd(SZSE:300314) is 1.34% (As of Today), Highest Dividend Payout Ratio of Ningbo David Medical Device Co Ltd(SZSE:300314) was 1. The lowest was 0.09. And the median was 0.37. The  Forward Dividend Yield % of Ningbo David Medical Device Co Ltd(SZSE:300314) is 1.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers